AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IBUPROFEN + PARACETAMOL + CAFFEINE
23 registrations across 5 African markets— 20 active
Markets with IBUPROFEN + PARACETAMOL + CAFFEINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| VON-P CAPSULES (Each capsules contains Ibuprofen/ Paracetamol/ Caffeine | 🇬🇭Ghana | — | active | Dec 2031 |
| VON-P CAPSULES (Each capsules contains Ibuprofen/ Paracetamol/ Caffeine | 🇬🇭Ghana | — | active | Dec 2031 |
| FENBASE EXTRA TABLETS (Each uncoated tablet contains Ibuprofen/Paracetamol/Caffeine 400mg/500mg/30mg) | 🇬🇭Ghana | — | active | Jan 2031 |
| FENBASE EXTRA TABLETS (Each uncoated tablet contains Ibuprofen/Paracetamol/Caffeine 400mg/500mg/30mg) | 🇬🇭Ghana | — | active | Jan 2031 |
| BUBU PR TABLET (Each Tablet Contains Ibuprofen/Paracetamol/Caffeine 200mg/325/30mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| BUBU PR TABLET (Each Tablet Contains Ibuprofen/Paracetamol/Caffeine 200mg/325/30mg) | 🇬🇭Ghana | — | active | Dec 2030 |
| TRIALGIC CAPSULES | 🇬🇭Ghana | — | active | Nov 2030 |
| TRIALGIC CAPSULES | 🇬🇭Ghana | — | active | Nov 2030 |
| Vamacap Plus Capsules Capsule | 🇳🇬Nigeria | Tuyil Pharmaceutical Industries Ltd | active | Aug 2029 |
| TRIALGIC Capsules | 🇷🇼Rwanda | Medreich Limited | active | Aug 2029 |
| Tobez Capsules** Capsule | 🇳🇬Nigeria | First Vadis Pharmaceutical Industries Limited | active | Nov 2028 |
| Ibukuka Capsules (check smpc) Capsule | 🇳🇬Nigeria | KCH Consumer Healthcare Limited | active | May 2028 |
| Brustan Extra Capsules Capsule | 🇳🇬Nigeria | Ranbaxy Nigeria Limited | active | Mar 2028 |
| Alfen Capsules Tablet | 🇳🇬Nigeria | Alben Health Care Industries Ltd | active | Feb 2028 |
| Biobucap Capsules Capsule | 🇳🇬Nigeria | Bioraj Pharmaceuticals Limited | active | Jan 2028 |
| Rabecom Capsule | 🇳🇬Nigeria | Nemel Pharmaceuticals Limited | active | Dec 2026 |
| Ibucap Capsules Capsule | 🇳🇬Nigeria | Shalina Healthcare Nigeria Limited | active | May 2026 |
| Peace Ibuprofen Extra Capsules Capsule | 🇳🇬Nigeria | Peace Standard Pharmaceutical Industries Limited | active | Sept 2025 |
| IBUCAP 200/325/30MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2025 |
| IBUCAP_FORTE 400/325/30MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2025 |
| IDUPLUS 200/325/40MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2024 |
| IBUPROFEN +
PARACETAMOL +
CAFFEINE ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
| IBUPROFEN +
PARACETAMOL +
CAFFEINE ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | GITTOES PHARMACEUTICA LS LIMITED | active | — |
IBUPROFEN + PARACETAMOL + CAFFEINE in Africa — Regulatory Overview
IBUPROFEN + PARACETAMOL + CAFFEINE is registered across 5 African markets with 23 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Ghana, Malawi, Uganda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 23 registrations, 20 (87%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.